Tag: finance
Revolut launches mid-tier subscription plan
Fintech startup Revolut is tweaking its subscription plans with a new mid-tier offering called Revolut — it costs £2.99 per month. Like N26 Smart and Monzo Plus, the new plan is a pandemic-proof package that doesn’t focus as much on travel. For the past couple of years, challenger banks and…
Read More
Sweden’s Tink raises $103M as its open banking platform grows to 3,400 banks and 250M customers
Open banking platforms, where services that might not have previously lived next to each other are now joined up by way of APIs, has been one of the emerging trends of the last couple of years, and today one of the leaders in the space out of Europe has closed…
Read More
Despite the pandemic, small business optimism persists
Kathryn Petralia Contributor Kathryn Petralia is the president and co-founder of Kabbage, an American Express Company providing small businesses cash flow solutions. Businesses and consumers alike are finding ways to adapt and stay resilient during these unprecedented times. Though recovery may take time, a new report confirms the strength of…
Read More
Making sense of Klarna
Sebastian Siemiatkowski, the co-founder and CEO of Klarna — the Swedish fintech “buy now, pay later” sensation that is currently Europe’s most valuable private tech company — is dismissive of the suggestion that non U.S. companies should relocate to Silicon Valley if they really want to grow. “We did hear…
Read More
Lemonade launches its renters insurance in France
Lemonade is launching its renters insurance in France. This is the company’s third European launch after the Netherlands and Germany. Originally from the U.S., Lemonade is now a public company with a current market capitalization close to $4 billion. Lemonade will compete directly with a local competitor called Luko. Both…
Read More
Bristol entrepreneur who exited for $800M doubles-down on the city with deep-tech incubator and VC fund
Harry Destecroix co-founded Ziylo while studying for his PhD at the University of Bristol. Ziylo, a university spin-out company, developed a synthetic molecule allowing glucose to bind with the bloodstream more effectively. Four years later, and by then a Phd, Destecroix sold the company to Danish firm Novo Nordisk, one…
Read More